Clinical utility of PET/CT in the evaluation of head and neck squamous cell carcinoma with an unknown primary: A prospective clinical trial

Background Metastatic head and neck squamous cell carcinoma with an unknown primary is an uncommon but important problem. PET/CT, as an adjunct to diagnosis, is potentially useful but has never been studied in a prospective, single‐blinded clinical trial. Methods In all, 20 subjects with cervical me...

Full description

Saved in:
Bibliographic Details
Published inHead & neck Vol. 33; no. 7; pp. 935 - 940
Main Authors Rudmik, Luke, Lau, Harold Y., Matthews, T. Wayne, Bosch, J. Douglas, Kloiber, Reinhard, Molnar, Christine P., Dort, Joseph C.
Format Journal Article
LanguageEnglish
Published Hoboken Wiley Subscription Services, Inc., A Wiley Company 01.07.2011
Wiley
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Background Metastatic head and neck squamous cell carcinoma with an unknown primary is an uncommon but important problem. PET/CT, as an adjunct to diagnosis, is potentially useful but has never been studied in a prospective, single‐blinded clinical trial. Methods In all, 20 subjects with cervical metastases from an unknown head and neck primary were enrolled in a prospective clinical trial. A standard protocol was used in both clinic and operating room (OR). Study surgeons were blinded to the PET/CT result upon completion of the standard work‐up. Results PET/CT increased the detection of a primary site from 25% to 55% (5 vs 11 subjects). This difference was statistically and clinically significant (p = .03, McNemar's test). There was 1 false negative PET/CT scan. Conclusions An unknown primary should be diagnosed only after a complete head and neck examination, flexible endoscopy, and CT or MRI. PET/CT performed prior to panendoscopy will increase the diagnostic yield in the unknown head and neck primary population, leading to more targeted, and less morbid, treatment. © 2010 Wiley Periodicals, Inc. Head Neck, 2011
AbstractList Metastatic head and neck squamous cell carcinoma with an unknown primary is an uncommon but important problem. PET/CT, as an adjunct to diagnosis, is potentially useful but has never been studied in a prospective, single-blinded clinical trial. In all, 20 subjects with cervical metastases from an unknown head and neck primary were enrolled in a prospective clinical trial. A standard protocol was used in both clinic and operating room (OR). Study surgeons were blinded to the PET/CT result upon completion of the standard work-up. PET/CT increased the detection of a primary site from 25% to 55% (5 vs 11 subjects). This difference was statistically and clinically significant (p = .03, McNemar's test). There was 1 false negative PET/CT scan. An unknown primary should be diagnosed only after a complete head and neck examination, flexible endoscopy, and CT or MRI. PET/CT performed prior to panendoscopy will increase the diagnostic yield in the unknown head and neck primary population, leading to more targeted, and less morbid, treatment.
Background Metastatic head and neck squamous cell carcinoma with an unknown primary is an uncommon but important problem. PET/CT, as an adjunct to diagnosis, is potentially useful but has never been studied in a prospective, single‐blinded clinical trial. Methods In all, 20 subjects with cervical metastases from an unknown head and neck primary were enrolled in a prospective clinical trial. A standard protocol was used in both clinic and operating room (OR). Study surgeons were blinded to the PET/CT result upon completion of the standard work‐up. Results PET/CT increased the detection of a primary site from 25% to 55% (5 vs 11 subjects). This difference was statistically and clinically significant (p = .03, McNemar's test). There was 1 false negative PET/CT scan. Conclusions An unknown primary should be diagnosed only after a complete head and neck examination, flexible endoscopy, and CT or MRI. PET/CT performed prior to panendoscopy will increase the diagnostic yield in the unknown head and neck primary population, leading to more targeted, and less morbid, treatment. © 2010 Wiley Periodicals, Inc. Head Neck, 2011
Metastatic head and neck squamous cell carcinoma with an unknown primary is an uncommon but important problem. PET/CT, as an adjunct to diagnosis, is potentially useful but has never been studied in a prospective, single-blinded clinical trial.BACKGROUNDMetastatic head and neck squamous cell carcinoma with an unknown primary is an uncommon but important problem. PET/CT, as an adjunct to diagnosis, is potentially useful but has never been studied in a prospective, single-blinded clinical trial.In all, 20 subjects with cervical metastases from an unknown head and neck primary were enrolled in a prospective clinical trial. A standard protocol was used in both clinic and operating room (OR). Study surgeons were blinded to the PET/CT result upon completion of the standard work-up.METHODSIn all, 20 subjects with cervical metastases from an unknown head and neck primary were enrolled in a prospective clinical trial. A standard protocol was used in both clinic and operating room (OR). Study surgeons were blinded to the PET/CT result upon completion of the standard work-up.PET/CT increased the detection of a primary site from 25% to 55% (5 vs 11 subjects). This difference was statistically and clinically significant (p = .03, McNemar's test). There was 1 false negative PET/CT scan.RESULTSPET/CT increased the detection of a primary site from 25% to 55% (5 vs 11 subjects). This difference was statistically and clinically significant (p = .03, McNemar's test). There was 1 false negative PET/CT scan.An unknown primary should be diagnosed only after a complete head and neck examination, flexible endoscopy, and CT or MRI. PET/CT performed prior to panendoscopy will increase the diagnostic yield in the unknown head and neck primary population, leading to more targeted, and less morbid, treatment.CONCLUSIONSAn unknown primary should be diagnosed only after a complete head and neck examination, flexible endoscopy, and CT or MRI. PET/CT performed prior to panendoscopy will increase the diagnostic yield in the unknown head and neck primary population, leading to more targeted, and less morbid, treatment.
Author Matthews, T. Wayne
Molnar, Christine P.
Kloiber, Reinhard
Rudmik, Luke
Dort, Joseph C.
Bosch, J. Douglas
Lau, Harold Y.
Author_xml – sequence: 1
  givenname: Luke
  surname: Rudmik
  fullname: Rudmik, Luke
  organization: Division of Otolaryngology-Head & Neck Surgery, Department of Surgery, University of Calgary, Calgary, Canada
– sequence: 2
  givenname: Harold Y.
  surname: Lau
  fullname: Lau, Harold Y.
  organization: Division of Radiation Oncology, Department of Oncology, University of Calgary, Calgary, Canada
– sequence: 3
  givenname: T. Wayne
  surname: Matthews
  fullname: Matthews, T. Wayne
  organization: Division of Otolaryngology-Head & Neck Surgery, Department of Surgery, University of Calgary, Calgary, Canada
– sequence: 4
  givenname: J. Douglas
  surname: Bosch
  fullname: Bosch, J. Douglas
  organization: Division of Otolaryngology-Head & Neck Surgery, Department of Surgery, University of Calgary, Calgary, Canada
– sequence: 5
  givenname: Reinhard
  surname: Kloiber
  fullname: Kloiber, Reinhard
  organization: Division of Nuclear Medicine, Department of Radiology, University of Calgary, Calgary, Canada
– sequence: 6
  givenname: Christine P.
  surname: Molnar
  fullname: Molnar, Christine P.
  organization: Division of Nuclear Medicine, Department of Radiology, University of Calgary, Calgary, Canada
– sequence: 7
  givenname: Joseph C.
  surname: Dort
  fullname: Dort, Joseph C.
  email: jdort@ucalgary.ca
  organization: Division of Otolaryngology-Head & Neck Surgery, Department of Surgery, University of Calgary, Calgary, Canada
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=24280686$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/21674668$$D View this record in MEDLINE/PubMed
BookMark eNp1kd9u0zAUxiM0xP7ABS-AfIMQF1nt2HEc7qbSdkhjIChwaZ04jmrqOFvsrPQZ9tJz1xQkBPKFj-Tfd46_850mR65zOkleEnxOMM4mK12fZyTn_ElyQnBZpJiy4mhXM5pSXLDj5NT7nxhjyln2LDnOCC8Y5-IkuZ9a44wCi4ZgrAlb1DXo82w5mS6RcSisNNJ3YAcIpnO7t5WGGoGrkdNqjfztAG03eKS0tUhBr4zrWkAbE1aRQoNbu27j0E1vWui379BFLDt_o1Uwdxqpw_DQG7DPk6cNWK9fjPdZ8m0-W04v06tPiw_Ti6tU0TLjaVPppqDAag4Kc8aoZqrkeZUVRSm4wCCAVIBBCUxYpeNhSjekVlDhMq8EPUve7PvGr9wO2gfZGr8zAE5HL1IUGaGYijySr0ZyqFpdy9GGPOwvAq9HAHz00fTglPF_OJYJzAWP3GTPqeje97qRyoTHnYYejJUEy12SMiYpH5OMird_KQ5N_8WO3TfG6u3_QXk5e39QpHuF8UH_-q2Afi15QYtc_rheyI-L-fzrNfsiv9MHRO29aQ
CitedBy_id crossref_primary_10_1002_cam4_1933
crossref_primary_10_4274_nts_galenos_2024_43153
crossref_primary_10_1016_j_rcl_2013_05_002
crossref_primary_10_1007_s00405_014_2980_z
crossref_primary_10_1002_lary_28200
crossref_primary_10_1007_s00761_012_2318_7
crossref_primary_10_1007_s00761_012_2315_x
crossref_primary_10_1002_hed_23830
crossref_primary_10_1097_MNM_0000000000001365
crossref_primary_10_1016_j_yoto_2011_10_003
crossref_primary_10_1007_s00259_015_3294_0
crossref_primary_10_1016_j_hoc_2021_05_004
crossref_primary_10_1016_j_jfma_2022_07_012
crossref_primary_10_1016_j_medcli_2012_04_033
crossref_primary_10_1002_hed_21898
crossref_primary_10_1056_NEJMra1303917
crossref_primary_10_11124_JBISRIR_2017_003476
crossref_primary_10_1002_lary_27625
crossref_primary_10_1016_j_otc_2013_04_011
crossref_primary_10_1111_ecc_13459
crossref_primary_10_1016_j_ijrobp_2017_02_217
crossref_primary_10_1177_0194599820933204
crossref_primary_10_1634_theoncologist_2015_0364
crossref_primary_10_1002_lary_27268
crossref_primary_10_1002_lary_23942
crossref_primary_10_1016_j_cpet_2014_09_006
crossref_primary_10_1007_s00259_021_05336_w
crossref_primary_10_1200_JCO_20_00275
crossref_primary_10_1007_s00259_014_2972_7
crossref_primary_10_2214_AJR_14_12828
crossref_primary_10_1002_hed_25026
crossref_primary_10_1016_j_coms_2019_07_007
crossref_primary_10_1016_j_ctrv_2015_05_010
crossref_primary_10_3390_surgeries3030022
crossref_primary_10_4329_wjr_v6_i6_238
crossref_primary_10_1053_j_sult_2017_05_008
crossref_primary_10_1186_s40463_017_0217_z
crossref_primary_10_17650_2222_1468_2019_9_2_35_42
crossref_primary_10_1016_j_cpet_2012_06_002
crossref_primary_10_1016_j_oraloncology_2019_03_014
crossref_primary_10_1016_j_jaad_2016_01_045
crossref_primary_10_1016_j_cpet_2015_05_002
crossref_primary_10_1186_1479_5876_10_12
crossref_primary_10_4329_wjr_v6_i5_177
crossref_primary_10_1002_hed_23372
crossref_primary_10_1007_s00106_017_0355_7
crossref_primary_10_1016_j_oraloncology_2012_05_022
crossref_primary_10_1016_j_clon_2012_08_007
crossref_primary_10_1016_j_cpet_2019_08_010
crossref_primary_10_1002_lary_27131
crossref_primary_10_1016_j_coms_2012_01_003
crossref_primary_10_1016_j_cpet_2012_06_007
crossref_primary_10_1016_j_critrevonc_2016_10_009
crossref_primary_10_1186_s40001_022_00957_9
crossref_primary_10_1007_s00259_015_3217_0
crossref_primary_10_1007_s40336_021_00429_w
crossref_primary_10_3904_kjm_2021_96_5_408
crossref_primary_10_4103_ijmpo_ijmpo_91_17
crossref_primary_10_1016_j_mric_2023_08_001
crossref_primary_10_1002_lary_25783
crossref_primary_10_1007_s00117_013_2548_8
crossref_primary_10_1007_s00405_014_3125_0
crossref_primary_10_1016_j_oraloncology_2024_107083
crossref_primary_10_1158_1078_0432_CCR_12_3030
crossref_primary_10_4103_jcrt_JCRT_1083_20
crossref_primary_10_1002_hed_23385
crossref_primary_10_1002_hed_25522
crossref_primary_10_1186_s40463_023_00623_y
Cites_doi 10.1067/mhn.2001.114309
10.1097/MNM.0b013e3280708edf
10.1177/1740774509102310
10.1155/2009/208725
10.1016/j.ctrv.2003.10.001
10.1097/00005537-199811000-00004
10.1002/cncr.20687
10.1016/j.oraloncology.2008.05.010
10.1016/S0197-2456(99)00017-3
10.6004/jnccn.2008.0080
10.1002/lary.20638
10.1002/(SICI)1097-0347(199812)20:8<739::AID-HED13>3.0.CO;2-0
10.1200/JCO.2008.17.8905
10.1002/1097-0142(19930901)72:5<1756::AID-CNCR2820720540>3.0.CO;2-5
10.1097/MLG.0b013e31805d017b
10.1002/cncr.22410
10.1002/hed.20734
10.1002/hed.20654
10.1016/S0167-8140(00)00172-9
ContentType Journal Article
Copyright Copyright © 2010 Wiley Periodicals, Inc.
2015 INIST-CNRS
Copyright_xml – notice: Copyright © 2010 Wiley Periodicals, Inc.
– notice: 2015 INIST-CNRS
DBID BSCLL
AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1002/hed.21566
DatabaseName Istex
CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE

MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
EISSN 1097-0347
EndPage 940
ExternalDocumentID 21674668
24280686
10_1002_hed_21566
HED21566
ark_67375_WNG_MGFFSN4R_V
Genre article
Journal Article
GrantInformation_xml – fundername: Ohlson Research Initiative, Faculty of Medicine, University of Calgary
– fundername: Calgary Surgical Education and Research Trust
GroupedDBID ---
.3N
.55
.GA
.Y3
05W
0R~
10A
1L6
1OB
1OC
1ZS
31~
33P
36B
3O-
3SF
3WU
4.4
4ZD
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AANLZ
AAONW
AASGY
AAXRX
AAZKR
ABCQN
ABCUV
ABEML
ABIJN
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFS
ACGOF
ACMXC
ACPOU
ACPRK
ACSCC
ACXBN
ACXQS
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADOZA
ADZMN
ADZOD
AEEZP
AEIGN
AEIMD
AEQDE
AEUQT
AEUYR
AFBPY
AFFPM
AFGKR
AFPWT
AFZJQ
AHBTC
AHMBA
AIACR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMBMR
AMYDB
ASPBG
ATUGU
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BROTX
BRXPI
BSCLL
BY8
C45
CS3
D-6
D-7
D-E
D-F
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DUUFO
EBD
EBS
EJD
EMB
EMOBN
F00
F01
F04
F5P
FEDTE
G-S
G.N
GNP
GODZA
H.X
HBH
HF~
HGLYW
HHY
HHZ
HVGLF
HZ~
IX1
J0M
JPC
KBYEO
KQQ
LATKE
LAW
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
M6P
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
NNB
O66
O9-
OIG
OVD
P2W
P2X
P2Z
P4B
P4D
PALCI
PQQKQ
Q.N
Q11
QB0
QRW
R.K
RIWAO
ROL
RWI
RX1
RYL
SAMSI
SUPJJ
SV3
TEORI
UB1
V2E
W8V
W99
WBKPD
WH7
WHWMO
WIH
WIJ
WIK
WJL
WOHZO
WQJ
WRC
WUP
WVDHM
WWO
WXI
WXSBR
X7M
XG1
XPP
XV2
ZGI
ZXP
ZZTAW
~IA
~WT
AAHQN
AAIPD
AAMNL
AANHP
AAYCA
ACRPL
ACYXJ
ADNMO
AFWVQ
ALVPJ
AAYXX
AEYWJ
AGHNM
AGQPQ
AGYGG
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ID FETCH-LOGICAL-c3926-fbef73a4d6ac06443e4c965b27798680a8a1ba0ac8014bebeb4cef1dcab095b83
IEDL.DBID DR2
ISSN 1043-3074
1097-0347
IngestDate Thu Jul 10 18:49:55 EDT 2025
Mon Jul 21 05:50:25 EDT 2025
Mon Jul 21 09:15:40 EDT 2025
Tue Jul 01 03:27:43 EDT 2025
Thu Apr 24 23:12:46 EDT 2025
Wed Jan 22 16:50:05 EST 2025
Wed Oct 30 09:53:12 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 7
Keywords Radionuclide study
head and neck imaging
Evaluation
Radiodiagnosis
Stomatology
unknown primary
ENT
Malignant tumor
clinical utility
PET/CT
Head and neck
Medical imagery
ENT disease
Head and neck cancer
Head and neck squamous cell carcinoma
Clinical trial
Computerized axial tomography
Positron emission tomography
Cancer
Emission tomography
Language English
License http://onlinelibrary.wiley.com/termsAndConditions#vor
CC BY 4.0
Copyright © 2010 Wiley Periodicals, Inc.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3926-fbef73a4d6ac06443e4c965b27798680a8a1ba0ac8014bebeb4cef1dcab095b83
Notes ark:/67375/WNG-MGFFSN4R-V
Ohlson Research Initiative, Faculty of Medicine, University of Calgary
istex:D1CDE97CCD998C6E417CA4B9D7D506ED429F1396
ArticleID:HED21566
Calgary Surgical Education and Research Trust
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 21674668
PQID 872130385
PQPubID 23479
PageCount 6
ParticipantIDs proquest_miscellaneous_872130385
pubmed_primary_21674668
pascalfrancis_primary_24280686
crossref_citationtrail_10_1002_hed_21566
crossref_primary_10_1002_hed_21566
wiley_primary_10_1002_hed_21566_HED21566
istex_primary_ark_67375_WNG_MGFFSN4R_V
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate July 2011
PublicationDateYYYYMMDD 2011-07-01
PublicationDate_xml – month: 07
  year: 2011
  text: July 2011
PublicationDecade 2010
PublicationPlace Hoboken
PublicationPlace_xml – name: Hoboken
– name: Hoboken, NJ
– name: United States
PublicationTitle Head & neck
PublicationTitleAlternate Head Neck
PublicationYear 2011
Publisher Wiley Subscription Services, Inc., A Wiley Company
Wiley
Publisher_xml – name: Wiley Subscription Services, Inc., A Wiley Company
– name: Wiley
References Freidlin B, Korn EL. Stopping clinical trials early for benefit: impact on estimation. Clin Trials 2009; 6: 119-125.
Mendenhall WM, Mancuso AA, Parsons JT, Stringer SP, Cassisi NJ. Diagnostic evaluation of squamous cell carcinoma metastatic to cervical lymph nodes from an unknown head and neck primary site. Head Neck 1998; 20: 739-744.
Fleming AJJr, Smith SPJr, Paul CM, et al. Impact of [18F]-2-fluorodeoxyglucose-positron emission tomography/computed tomography on previously untreated head and neck cancer patients. Laryngoscope 2007; 117: 1173-1179.
Galer CE, Kies MS. Evaluation and management of the unknown primary carcinoma of the head and neck. J Natl Compr Canc Netw 2008; 6: 1068-1075.
Wartski M, Le Stanc E, Gontier E, et al. In search of an unknown primary tumour presenting with cervical metastases: performance of hybrid FDG-PET/CT. Nucl Med Commun 2007; 28: 365-371.
Rusthoven KE, Koshy M, Paulino AC. The role of fluorodeoxyglucose positron emission tomography in cervical lymph node metastases from an unknown primary tumor. Cancer 2004; 101: 2641-2649.
Miller FR, Karnad AB, Eng T, Hussey DH, Stan McGuff H, Otto RA. Management of the unknown primary carcinoma: long-term follow-up on a negative PET scan and negative panendoscopy. Head Neck 2008; 30: 28-34.
McQuone SJ, Eisele DW, Lee DJ, Westra WH, Koch WM. Occult tonsillar carcinoma in the unknown primary. Laryngoscope 1998; 108: 1605-1610.
Roh JL, Kim JS, Lee JH, et al. Utility of combined (18)F-fluorodeoxyglucose-positron emission tomography and computed tomography in patients with cervical metastases from unknown primary tumors. Oral Oncol 2009; 45: 218-224.
Freidlin B, Korn EL, George SL. Data monitoring committees and interim monitoring guidelines. Control Clin Trials 1999; 20: 395-407.
Jereczek-Fossa BA, Jassem J, Orecchia R. Cervical lymph node metastases of squamous cell carcinoma from an unknown primary. Cancer Treat Rev 2004; 30: 153-164.
Johansen J, Buus S, Loft A, et al. Prospective study of 18FDG-PET in the detection and management of patients with lymph node metastases to the neck from an unknown primary tumor. Results from the DAHANCA-13 study. Head Neck 2008; 30: 471-478.
Seve P, Billotey C, Broussolle C, Dumontet C, Mackey JR. The role of 2-deoxy-2-[F-18]fluoro-D-glucose positron emission tomography in disseminated carcinoma of unknown primary site. Cancer 2007; 109: 292-299.
Cianchetti M, Mancuso AA, Amdur RJ, et al. Diagnostic evaluation of squamous cell carcinoma metastatic to cervical lymph nodes from an unknown head and neck primary site. Laryngoscope 2009; 119: 2348-2354.
Al-Ibraheem A, Buck A, Krause BJ, Scheidhauer K, Schwaiger M. Clinical applications of FDG PET and PET/CT in head and neck cancer. J Oncol 2009; 208725: 1-13.
Freidlin B, Korn EL. Monitoring for lack of benefit: a critical component of a randomized clinical trial. J Clin Oncol 2009; 27: 629-633.
Jones AS, Cook JA, Phillips DE, Roland NR. Squamous carcinoma presenting as an enlarged cervical lymph node. Cancer 1993; 72: 1756-1761.
Grau C, Johansen LV, Jakobsen J, Geertsen P, Andersen E, Jensen BB. Cervical lymph node metastases from unknown primary tumours. Results from a national survey by the Danish Society for Head and Neck Oncology. Radiother Oncol 2000; 55: 121-129.
Koch WM, Bhatti N, Williams MF, Eisele DW. Oncologic rationale for bilateral tonsillectomy in head and neck squamous cell carcinoma of unknown primary source. Otolaryngol Head Neck Surg 2001; 124: 331-333.
2004; 101
2007; 28
2009; 45
2004; 30
2001; 124
2007; 117
1993; 72
2000; 55
1998; 108
1999; 20
2008; 6
2009; 6
2008; 30
2009; 119
2007; 109
1998; 20
2009; 27
2009; 208725
e_1_2_7_5_2
e_1_2_7_4_2
e_1_2_7_3_2
e_1_2_7_2_2
e_1_2_7_9_2
e_1_2_7_8_2
e_1_2_7_7_2
e_1_2_7_6_2
e_1_2_7_19_2
e_1_2_7_18_2
e_1_2_7_17_2
e_1_2_7_16_2
e_1_2_7_15_2
e_1_2_7_14_2
e_1_2_7_13_2
e_1_2_7_12_2
e_1_2_7_11_2
e_1_2_7_10_2
e_1_2_7_20_2
22638936 - Strahlenther Onkol. 2012 Jul;188(7):637-8
References_xml – reference: Jones AS, Cook JA, Phillips DE, Roland NR. Squamous carcinoma presenting as an enlarged cervical lymph node. Cancer 1993; 72: 1756-1761.
– reference: Al-Ibraheem A, Buck A, Krause BJ, Scheidhauer K, Schwaiger M. Clinical applications of FDG PET and PET/CT in head and neck cancer. J Oncol 2009; 208725: 1-13.
– reference: Wartski M, Le Stanc E, Gontier E, et al. In search of an unknown primary tumour presenting with cervical metastases: performance of hybrid FDG-PET/CT. Nucl Med Commun 2007; 28: 365-371.
– reference: Rusthoven KE, Koshy M, Paulino AC. The role of fluorodeoxyglucose positron emission tomography in cervical lymph node metastases from an unknown primary tumor. Cancer 2004; 101: 2641-2649.
– reference: Jereczek-Fossa BA, Jassem J, Orecchia R. Cervical lymph node metastases of squamous cell carcinoma from an unknown primary. Cancer Treat Rev 2004; 30: 153-164.
– reference: Mendenhall WM, Mancuso AA, Parsons JT, Stringer SP, Cassisi NJ. Diagnostic evaluation of squamous cell carcinoma metastatic to cervical lymph nodes from an unknown head and neck primary site. Head Neck 1998; 20: 739-744.
– reference: Freidlin B, Korn EL. Stopping clinical trials early for benefit: impact on estimation. Clin Trials 2009; 6: 119-125.
– reference: Seve P, Billotey C, Broussolle C, Dumontet C, Mackey JR. The role of 2-deoxy-2-[F-18]fluoro-D-glucose positron emission tomography in disseminated carcinoma of unknown primary site. Cancer 2007; 109: 292-299.
– reference: Cianchetti M, Mancuso AA, Amdur RJ, et al. Diagnostic evaluation of squamous cell carcinoma metastatic to cervical lymph nodes from an unknown head and neck primary site. Laryngoscope 2009; 119: 2348-2354.
– reference: Roh JL, Kim JS, Lee JH, et al. Utility of combined (18)F-fluorodeoxyglucose-positron emission tomography and computed tomography in patients with cervical metastases from unknown primary tumors. Oral Oncol 2009; 45: 218-224.
– reference: Koch WM, Bhatti N, Williams MF, Eisele DW. Oncologic rationale for bilateral tonsillectomy in head and neck squamous cell carcinoma of unknown primary source. Otolaryngol Head Neck Surg 2001; 124: 331-333.
– reference: Johansen J, Buus S, Loft A, et al. Prospective study of 18FDG-PET in the detection and management of patients with lymph node metastases to the neck from an unknown primary tumor. Results from the DAHANCA-13 study. Head Neck 2008; 30: 471-478.
– reference: Fleming AJJr, Smith SPJr, Paul CM, et al. Impact of [18F]-2-fluorodeoxyglucose-positron emission tomography/computed tomography on previously untreated head and neck cancer patients. Laryngoscope 2007; 117: 1173-1179.
– reference: Galer CE, Kies MS. Evaluation and management of the unknown primary carcinoma of the head and neck. J Natl Compr Canc Netw 2008; 6: 1068-1075.
– reference: Miller FR, Karnad AB, Eng T, Hussey DH, Stan McGuff H, Otto RA. Management of the unknown primary carcinoma: long-term follow-up on a negative PET scan and negative panendoscopy. Head Neck 2008; 30: 28-34.
– reference: Grau C, Johansen LV, Jakobsen J, Geertsen P, Andersen E, Jensen BB. Cervical lymph node metastases from unknown primary tumours. Results from a national survey by the Danish Society for Head and Neck Oncology. Radiother Oncol 2000; 55: 121-129.
– reference: McQuone SJ, Eisele DW, Lee DJ, Westra WH, Koch WM. Occult tonsillar carcinoma in the unknown primary. Laryngoscope 1998; 108: 1605-1610.
– reference: Freidlin B, Korn EL, George SL. Data monitoring committees and interim monitoring guidelines. Control Clin Trials 1999; 20: 395-407.
– reference: Freidlin B, Korn EL. Monitoring for lack of benefit: a critical component of a randomized clinical trial. J Clin Oncol 2009; 27: 629-633.
– volume: 124
  start-page: 331
  year: 2001
  end-page: 333
  article-title: Oncologic rationale for bilateral tonsillectomy in head and neck squamous cell carcinoma of unknown primary source
  publication-title: Otolaryngol Head Neck Surg
– volume: 30
  start-page: 28
  year: 2008
  end-page: 34
  article-title: Management of the unknown primary carcinoma: long‐term follow‐up on a negative PET scan and negative panendoscopy
  publication-title: Head Neck
– volume: 6
  start-page: 1068
  year: 2008
  end-page: 1075
  article-title: Evaluation and management of the unknown primary carcinoma of the head and neck
  publication-title: J Natl Compr Canc Netw
– volume: 6
  start-page: 119
  year: 2009
  end-page: 125
  article-title: Stopping clinical trials early for benefit: impact on estimation
  publication-title: Clin Trials
– volume: 108
  start-page: 1605
  year: 1998
  end-page: 1610
  article-title: Occult tonsillar carcinoma in the unknown primary
  publication-title: Laryngoscope
– volume: 119
  start-page: 2348
  year: 2009
  end-page: 2354
  article-title: Diagnostic evaluation of squamous cell carcinoma metastatic to cervical lymph nodes from an unknown head and neck primary site
  publication-title: Laryngoscope
– volume: 20
  start-page: 739
  year: 1998
  end-page: 744
  article-title: Diagnostic evaluation of squamous cell carcinoma metastatic to cervical lymph nodes from an unknown head and neck primary site
  publication-title: Head Neck
– volume: 101
  start-page: 2641
  year: 2004
  end-page: 2649
  article-title: The role of fluorodeoxyglucose positron emission tomography in cervical lymph node metastases from an unknown primary tumor
  publication-title: Cancer
– volume: 55
  start-page: 121
  year: 2000
  end-page: 129
  article-title: Cervical lymph node metastases from unknown primary tumours. Results from a national survey by the Danish Society for Head and Neck Oncology
  publication-title: Radiother Oncol
– volume: 30
  start-page: 153
  year: 2004
  end-page: 164
  article-title: Cervical lymph node metastases of squamous cell carcinoma from an unknown primary
  publication-title: Cancer Treat Rev
– volume: 27
  start-page: 629
  year: 2009
  end-page: 633
  article-title: Monitoring for lack of benefit: a critical component of a randomized clinical trial
  publication-title: J Clin Oncol
– volume: 109
  start-page: 292
  year: 2007
  end-page: 299
  article-title: The role of 2‐deoxy‐2‐[F‐18]fluoro‐D‐glucose positron emission tomography in disseminated carcinoma of unknown primary site
  publication-title: Cancer
– volume: 45
  start-page: 218
  year: 2009
  end-page: 224
  article-title: Utility of combined (18)F‐fluorodeoxyglucose‐positron emission tomography and computed tomography in patients with cervical metastases from unknown primary tumors
  publication-title: Oral Oncol
– volume: 72
  start-page: 1756
  year: 1993
  end-page: 1761
  article-title: Squamous carcinoma presenting as an enlarged cervical lymph node
  publication-title: Cancer
– volume: 208725
  start-page: 1
  year: 2009
  end-page: 13
  article-title: Clinical applications of FDG PET and PET/CT in head and neck cancer
  publication-title: J Oncol
– volume: 30
  start-page: 471
  year: 2008
  end-page: 478
  article-title: Prospective study of 18FDG‐PET in the detection and management of patients with lymph node metastases to the neck from an unknown primary tumor. Results from the DAHANCA‐13 study
  publication-title: Head Neck
– volume: 20
  start-page: 395
  year: 1999
  end-page: 407
  article-title: Data monitoring committees and interim monitoring guidelines
  publication-title: Control Clin Trials
– volume: 117
  start-page: 1173
  year: 2007
  end-page: 1179
  article-title: Impact of [18F]‐2‐fluorodeoxyglucose‐positron emission tomography/computed tomography on previously untreated head and neck cancer patients
  publication-title: Laryngoscope
– volume: 28
  start-page: 365
  year: 2007
  end-page: 371
  article-title: In search of an unknown primary tumour presenting with cervical metastases: performance of hybrid FDG‐PET/CT
  publication-title: Nucl Med Commun
– ident: e_1_2_7_19_2
  doi: 10.1067/mhn.2001.114309
– ident: e_1_2_7_14_2
  doi: 10.1097/MNM.0b013e3280708edf
– ident: e_1_2_7_15_2
  doi: 10.1177/1740774509102310
– ident: e_1_2_7_11_2
  doi: 10.1155/2009/208725
– ident: e_1_2_7_4_2
  doi: 10.1016/j.ctrv.2003.10.001
– ident: e_1_2_7_20_2
  doi: 10.1097/00005537-199811000-00004
– ident: e_1_2_7_12_2
  doi: 10.1002/cncr.20687
– ident: e_1_2_7_17_2
  doi: 10.1016/j.oraloncology.2008.05.010
– ident: e_1_2_7_18_2
  doi: 10.1016/S0197-2456(99)00017-3
– ident: e_1_2_7_2_2
  doi: 10.6004/jnccn.2008.0080
– ident: e_1_2_7_7_2
  doi: 10.1002/lary.20638
– ident: e_1_2_7_8_2
  doi: 10.1002/(SICI)1097-0347(199812)20:8<739::AID-HED13>3.0.CO;2-0
– ident: e_1_2_7_16_2
  doi: 10.1200/JCO.2008.17.8905
– ident: e_1_2_7_6_2
  doi: 10.1002/1097-0142(19930901)72:5<1756::AID-CNCR2820720540>3.0.CO;2-5
– ident: e_1_2_7_13_2
  doi: 10.1097/MLG.0b013e31805d017b
– ident: e_1_2_7_10_2
  doi: 10.1002/cncr.22410
– ident: e_1_2_7_9_2
  doi: 10.1002/hed.20734
– ident: e_1_2_7_5_2
  doi: 10.1002/hed.20654
– ident: e_1_2_7_3_2
  doi: 10.1016/S0167-8140(00)00172-9
– reference: 22638936 - Strahlenther Onkol. 2012 Jul;188(7):637-8
SSID ssj0003642
Score 2.3084054
Snippet Background Metastatic head and neck squamous cell carcinoma with an unknown primary is an uncommon but important problem. PET/CT, as an adjunct to diagnosis,...
Metastatic head and neck squamous cell carcinoma with an unknown primary is an uncommon but important problem. PET/CT, as an adjunct to diagnosis, is...
SourceID proquest
pubmed
pascalfrancis
crossref
wiley
istex
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 935
SubjectTerms Adult
Aged
Aged, 80 and over
Biological and medical sciences
Carcinoma, Squamous Cell - diagnosis
Carcinoma, Squamous Cell - secondary
clinical utility
Female
head and neck imaging
Head and Neck Neoplasms - diagnosis
Head and Neck Neoplasms - pathology
Head and Neck Neoplasms - secondary
head and neck squamous cell carcinoma
Humans
Male
Medical sciences
Middle Aged
Neoplasms, Unknown Primary - diagnosis
Otorhinolaryngology (head neck, general aspects and miscellaneous)
Otorhinolaryngology. Stomatology
PET/CT
Positron-Emission Tomography
Predictive Value of Tests
Preoperative Period
Prospective Studies
Squamous Cell Carcinoma of Head and Neck
Tomography, X-Ray Computed
Tumors
unknown primary
Title Clinical utility of PET/CT in the evaluation of head and neck squamous cell carcinoma with an unknown primary: A prospective clinical trial
URI https://api.istex.fr/ark:/67375/WNG-MGFFSN4R-V/fulltext.pdf
https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fhed.21566
https://www.ncbi.nlm.nih.gov/pubmed/21674668
https://www.proquest.com/docview/872130385
Volume 33
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LixQxEA7LevHiA1_jYylExEvPozudTutpWWd2EHaQdVb3IIRKOs3KrBndmQHxL_inrerXMLKCeGs6FehUV5IvlaqvhHhBC56iBhkRtEV23YwijIs0GtpYqjgvdFwV7TuZqemZfHeenu-JN20uTM0P0TnceGZU6zVPcLSrwZY09MIX_ZhPH7T-cqwWA6LTLXVUomR90ykT9q_IllVoGA-6njt70Q1W6w-OjcQVqaes61pcBzx3cWy1EU1ui8_tEOr4k0V_s7Z99_MPdsf_HOMdcasBqHBYW9RdsefDPfGroQ-9BLJTBu6wLOH9eD44msOXAAQiYUsbzm20xBeAoYDg3QJW3zfILgbgawJwXL4oLL8isBOYpGAT2LUX4FtNffEaDulx2SaBQpu9CVWJkfvibDKeH02jpoxD5Ah8qai0vswSlIVCRwBIJl66XKU2zrJcKz1EjSOLQ3RMZGPJqKx0vhwVDi3hP6uTB2I_LIN_JED7VHptiwQR-cpW04s8L1A7Z0eZK3viVftDjWs4zrnUxqWp2ZljQxo1lUZ74nkn2ozuOqGXlVV0Eni14Ei4LDWfZsfm5Hgy-TCTp-ZjTxzsmE3XgRCQ5iycnoDWjgxNYFY3Bk-aN5rO4Anfz_bEw9q-tp05RUQpTcOqrOTvH2qm47fVw-N_F30ibtYOco49fir211cb_4wQ1toeVFPpN0OvIk0
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LbxMxELZKe4ALD_FaHmWEEOKyeex6HS_iUpWkAZoIlRR6qSzb6xUoxYE2kRB_gT_NjPcRBRUJcVutx9J6dmx_nvF8w9gzXPAENvAYoa0m100_1kmRxT2TcJHkhUxC0b7JVIyP-duT7GSLvWpyYSp-iNbhRjMjrNc0wckh3V2zhn52RSeh48cVtkMVvcOB6mhNHpUKXsU6eUoeFt7wCvWSbtt1YzfaIcX-oNuR-gIVVFaVLS6DnptINmxFoxvstBlEdQNl3lktTcf-_IPf8X9HeZNdrzEq7FVGdYttOX-b_aoZRM8ATZWwOyxKeD-cdfdn8MUD4khYM4dTG67yBWhfgHd2DhffV5q8DECRArBUwcgvvmogPzBKwcqTd8_Dt4r94iXs4eOiyQOFJoETQpWRO-x4NJztj-O6kkNsEX-JuDSuHKSaF0JbxEA8ddzmIjPJYJBLIXta6r7RPW2Jy8agXRluXdkvrDYIAY1M77Jtv_DuPgPpMu6kKVKtNUVtJb7I80JLa01_YMuIvWj-qLI1zTlV2zhTFUFzolCjKmg0Yk9b0Xp0lwk9D2bRSujzOV2GG2Tq0_RATQ5Gow9TfqQ-Rmx3w27aDgiCJCXiRAwaQ1I4h0nd2jvUvJJ4DE8pRBuxe5WBrTtTlogQEocVzOTvH6rGw9fh4cG_iz5hV8ezyaE6fDN995Bdq_zldBX5Edtenq_cYwRcS7Mb5tVvRVUmaA
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLbGJiFeuIhbBgwLIcRL2jRxHAeeprVZuayaRgd7mGT5FoG6uWNrJcRf4E9zTm5V0ZAQb1FyLMUnn-0vxz7fIeQlTHgcHrAQqK3C0M0gVLFNw0jHjMe5FXFVtO9gwsfH7P1JerJB3ra5MLU-RBdww5FRzdc4wC9s2V-Jhn51thfj38cNssV4JBDSw6OVdlTCWb3VyRIMsLBWViiK-13TtcVoC_36Aw9HqivwT1kXtriOea4T2WolKu6Q07YP9QGUWW-50D3z8w95x__s5F1yu2GodLeG1D2y4fx98qvRDz2jAFRk7nRe0sPRtL83pd88BRZJV7rh-AzmeEuVt9Q7M6NX35cKYwwU9wmowfpFfn6uKEaBwYouPcb2PL2otS_e0F24nLdZoLRN36RVjZEH5LgYTffGYVPHITTAvnhYaldmiWKWKwMMiCWOmZynOs6yXHARKaEGWkXKoJKNBlRpZlw5sEZpIIBaJA_Jpp9795hQ4VLmhLaJUgr3bAXcyHOrhDF6kJkyIK_bDypNI3KOtTbOZC3PHEvwqKw8GpAXnWnTu-uMXlWo6CzU5QyPwmWp_DLZlwf7RfFpwo7k54DsrMGmawAUSGAaTkBoiyMJIxjdrbwDz0sBP-EJbtAG5FGNr1VjzBHhXEC3KpT8_UXleDSsLrb_3fQ5uXk4LOTHd5MPT8itOliO55Cfks3F5dI9A7a10DvVqPoN3GMlIA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Clinical+utility+of+PET%2FCT+in+the+evaluation+of+head+and+neck+squamous+cell+carcinoma+with+an+unknown+primary%3A+a+prospective+clinical+trial&rft.jtitle=Head+%26+neck&rft.au=Rudmik%2C+Luke&rft.au=Lau%2C+Harold+Y&rft.au=Matthews%2C+T+Wayne&rft.au=Bosch%2C+J+Douglas&rft.date=2011-07-01&rft.eissn=1097-0347&rft.volume=33&rft.issue=7&rft.spage=935&rft_id=info:doi/10.1002%2Fhed.21566&rft_id=info%3Apmid%2F21674668&rft.externalDocID=21674668
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1043-3074&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1043-3074&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1043-3074&client=summon